Nuveen
KYTX icon

Nuveen’s Kyverna Therapeutics KYTX Stock Holding History

Nuveen’s Portfolio KYTX Stock Details KYTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.08M Buy
+233,743
New +$2.08M ﹤0.01% 2557
2025
Q2 		– Sell
-47,508
Closed -$91.7K – 3432
2025
Q1 		$91.7K Buy
47,508
+24,660
+108% +$72.9K ﹤0.01% 3224
2024
Q4 		$85.5K Hold
22,848
– – ﹤0.01% 3299
2024
Q3 		$112K Hold
22,848
– – ﹤0.01% 3299
2024
Q2 		$171K Buy
+22,848
New +$349K ﹤0.01% 3245

Other funds holding KYTX

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
IHG
Insight Holdings Group New York $1.32B AUM 1.62% 1-Year Est. Return

Nuveen's KYTX Position: Q2 2026 in Review

Nuveen opened a new position in Kyverna Therapeutics (KYTX) in Q2 2026: 233,743 shares worth $2.08M. The stake represents ﹤0.01% of the portfolio and ranks #2557 among its holdings. This is a return to the name: Nuveen previously reported a position in KYTX as recently as Q1 2025.

Nuveen first reported a position in KYTX in Q2 2024 and has held it in 5 quarters since. 120 funds tracked by Wall St. Rank hold KYTX as of Q2 2026.

  • Nuveen held 233,743 shares of Kyverna Therapeutics worth $2.08M as of Q2 2026.
  • Kyverna Therapeutics was a new Nuveen position in Q2 2026.
  • Kyverna Therapeutics made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2557 holding.
  • Nuveen first reported a position in Kyverna Therapeutics in Q2 2024 and has held it in 5 quarters since.
  • 120 funds tracked by Wall St. Rank held Kyverna Therapeutics as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.